(Q58244375)

English

The welfare effects of innovative pharmaceuticals: an international perspective from the Dutch experience

No description defined

In more languages

edit

Statements

instance of

scholarly article

0 references

title

The welfare effects of innovative pharmaceuticals: an international perspective from the Dutch experience (English)

0 references

author name string

Apostolos Tsiachristas†

series ordinal

1

0 references

René Goudriaan

series ordinal

2

0 references

Wim Groot

series ordinal

3

0 references

publication date

March 2013

0 references

published in

Applied Economics

0 references

volume

45

0 references

page(s)

1219-1226

0 references

issue

9

0 references

cites work

Bias in published cost effectiveness studies: systematic review

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1080%2F00036846.2011.628296

retrieved

21 January 2018

Need for differential discounting of costs and health effects in cost effectiveness analyses

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1080%2F00036846.2011.628296

retrieved

21 January 2018

The role of medical care in contributing to health improvements within societies.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1080%2F00036846.2011.628296

retrieved

21 January 2018

Improving health: measuring effects of medical care

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1080%2F00036846.2011.628296

retrieved

21 January 2018

Patient access to pharmaceuticals: an international comparison

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1080%2F00036846.2011.628296

retrieved

21 January 2018

Public and private pharmaceutical spending as determinants of health outcomes in Canada.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1080%2F00036846.2011.628296

retrieved

21 January 2018

Do drugs reduce utilisation of other healthcare resources?

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1080%2F00036846.2011.628296

retrieved

21 January 2018

The value of antihypertensive drugs: a perspective on medical innovation.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1080%2F00036846.2011.628296

retrieved

21 January 2018

A direct method for estimating the compensating income variation for severe headache and migraine

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1080%2F00036846.2011.628296

retrieved

21 January 2018

The effect of using newer drugs on admissions of elderly Americans to hospitals and nursing homes: state-level evidence from 1997 to 2003.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1080%2F00036846.2011.628296

retrieved

21 January 2018

Is the Food and Drug Administration safe and effective?

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1080%2F00036846.2011.628296

retrieved

21 January 2018

National Institute for Clinical Excellence and its value judgments

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1080%2F00036846.2011.628296

retrieved

21 January 2018

Penny and pound wise: pharmacoeconomics from a governmental perspective

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1080%2F00036846.2011.628296

retrieved

21 January 2018

Identifiers

DOI

10.1080/00036846.2011.628296

0 references

(Q58244375)

The welfare effects of innovative pharmaceuticals: an international perspective from the Dutch experience

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)